A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI

Clinical trial NCT01848106 · TERMINATED

Trial details

NCT number: NCT01848106
Sponsor: Regado Biosciences, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2013-09-01
Primary completion: 2014-08-01
Enrollment: 3232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.